U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch) · United States

FDA Guidance - Communications Consistent with FDA-Required Labeling (CFL)

Data in promotion that are not in the labeling, including real-world evidence, must be consistent with the approved conditions of use and be presented with the study design, limitations and context needed to avoid misleading the reader.

21 U.S.C. 352(a), (n); 21 CFR 202.1(e)(6); FDA CFL Q&A Guidance (2018)

What is FDA Guidance - Communications Consistent with FDA-Required Labeling (CFL)?

Data in promotion that are not in the labeling, including real-world evidence, must be consistent with the approved conditions of use and be presented with the study design, limitations and context needed to avoid misleading the reader. Apply to promotional assets that present study data, real-world evidence or outcomes data about a prescription drug beyond its labeling.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-10-07

What does this rule require?

Data in promotion that are not in the labeling, including real-world evidence, must be consistent with the approved conditions of use and be presented with the study design, limitations and context needed to avoid misleading the reader.

How can marketing teams comply?

Apply to promotional assets that present study data, real-world evidence or outcomes data about a prescription drug beyond its labeling.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch)
Jurisdiction
United States
Official citation
21 U.S.C. 352(a), (n); 21 CFR 202.1(e)(6); FDA CFL Q&A Guidance (2018)
Published
2026-11-16
Effective date
2026-10-07
Channel
all_channels
Products
Prescription Drug
Audiences
general_audience, general_adults_18plus, customers, health_professionals, patients

Frequently asked questions

What is FDA Guidance - Communications Consistent with FDA-Required Labeling (CFL)?

Data in promotion that are not in the labeling, including real-world evidence, must be consistent with the approved conditions of use and be presented with the study design, limitations and context needed to avoid misleading the reader.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-10-07

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan